Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study
- PMID: 17327887
- DOI: 10.1038/sj.npp.1301347
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study
Abstract
Recent volumetric magnetic resonance imaging (MRI) studies have suggested brain volume changes in schizophrenia to be progressive in nature. Whether this is a global process or some brain areas are more affected than others is not known. In a 5-year longitudinal study, MRI whole brain scans were obtained from 96 patients with schizophrenia and 113 matched healthy comparison subjects. Changes over time in focal gray and white matter were measured with voxel-based morphometry throughout the brain. Over the 5-year interval, excessive decreases in gray matter density were found in patients in the left superior frontal area (Brodmann areas 9/10), left superior temporal gyrus (Brodmann area 42), right caudate nucleus, and right thalamus as compared to healthy individuals. Excessive gray matter density decrease in the superior frontal gray matter was related to increased number of hospitalizations, whereas a higher cumulative dose of clozapine and olanzapine during the scan interval was related to lesser decreases in this area. In conclusion, gray matter density loss occurs across the course of the illness in schizophrenia, predominantly in left frontal and temporal cortices. Moreover, the progression in left frontal density loss appears to be related to an increased number of psychotic episodes, with atypical antipsychotic medication attenuating these changes.
Similar articles
-
Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.Psychiatry Res. 2006 Dec 1;148(2-3):121-32. doi: 10.1016/j.pscychresns.2006.04.008. Epub 2006 Nov 9. Psychiatry Res. 2006. PMID: 17097276 Clinical Trial.
-
Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.Schizophr Res. 2008 Jan;98(1-3):29-39. doi: 10.1016/j.schres.2007.05.012. Epub 2007 Oct 31. Schizophr Res. 2008. PMID: 17976957
-
A follow-up MRI study of the fusiform gyrus and middle and inferior temporal gyri in schizophrenia spectrum.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1957-64. doi: 10.1016/j.pnpbp.2011.07.009. Epub 2011 Jul 27. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21820482
-
Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies.Biol Psychiatry. 2011 Jul 1;70(1):88-96. doi: 10.1016/j.biopsych.2011.01.032. Epub 2011 Mar 31. Biol Psychiatry. 2011. PMID: 21457946
-
Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings.Schizophr Res. 2013 Mar;144(1-3):37-42. doi: 10.1016/j.schres.2012.12.018. Epub 2013 Jan 27. Schizophr Res. 2013. PMID: 23360727 Review.
Cited by
-
Association of MTHFR C677T polymorphism with schizophrenia and its effect on episodic memory and gray matter density in patients.Behav Brain Res. 2013 Apr 15;243:146-52. doi: 10.1016/j.bbr.2012.12.061. Epub 2013 Jan 12. Behav Brain Res. 2013. PMID: 23318463 Free PMC article.
-
Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.Neurobiol Dis. 2013 May;53:18-25. doi: 10.1016/j.nbd.2012.10.022. Epub 2012 Oct 31. Neurobiol Dis. 2013. PMID: 23123218 Free PMC article. Review.
-
Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.Int J Neuropsychopharmacol. 2020 Dec 29;23(12):799-810. doi: 10.1093/ijnp/pyaa061. Int J Neuropsychopharmacol. 2020. PMID: 32808036 Free PMC article.
-
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia.Drug Des Devel Ther. 2016 May 24;10:1731-42. doi: 10.2147/DDDT.S86301. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27307704 Free PMC article. Review.
-
A new multimodality fusion classification approach to explore the uniqueness of schizophrenia and autism spectrum disorder.Hum Brain Mapp. 2022 Aug 15;43(12):3887-3903. doi: 10.1002/hbm.25890. Epub 2022 Apr 29. Hum Brain Mapp. 2022. PMID: 35484969 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical